6.18
price down icon0.40%   -0.025
after-market Handel nachbörslich: 6.18
loading
Schlusskurs vom Vortag:
$6.205
Offen:
$6.26
24-Stunden-Volumen:
851.55K
Relative Volume:
1.30
Marktkapitalisierung:
$295.87M
Einnahmen:
$15.84M
Nettoeinkommen (Verlust:
$-308.48M
KGV:
-1.5685
EPS:
-3.94
Netto-Cashflow:
$-153.08M
1W Leistung:
-19.32%
1M Leistung:
-3.74%
6M Leistung:
+23.35%
1J Leistung:
-10.30%
1-Tages-Spanne:
Value
$5.87
$6.31
1-Wochen-Bereich:
Value
$5.87
$7.505
52-Wochen-Spanne:
Value
$3.73
$11.35

Uniqure N V Stock (QURE) Company Profile

Name
Firmenname
Uniqure N V
Name
Telefon
1-339-970-7000
Name
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Name
Mitarbeiter
480
Name
Twitter
@uniQure_NV
Name
Nächster Verdiensttermin
2024-07-30
Name
Neueste SEC-Einreichungen
Name
QURE's Discussions on Twitter

Vergleichen Sie QURE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
QURE 6.18 295.87M 15.84M -308.48M -153.08M -3.94
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Uniqure N V Stock (QURE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-03-17 Hochstufung UBS Neutral → Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-21 Eingeleitet UBS Neutral
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-01 Hochstufung Mizuho Neutral → Buy
2021-01-07 Hochstufung Guggenheim Neutral → Buy
2020-11-24 Eingeleitet H.C. Wainwright Buy
2020-11-11 Eingeleitet Berenberg Buy
2020-11-09 Eingeleitet Jefferies Buy
2020-11-04 Eingeleitet Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet RBC Capital Mkts Outperform
2020-08-25 Eingeleitet Raymond James Strong Buy
2020-07-31 Hochstufung Robert W. Baird Neutral → Outperform
2020-06-25 Herabstufung Mizuho Buy → Neutral
2020-06-25 Herabstufung Robert W. Baird Outperform → Neutral
2020-06-25 Herabstufung Wells Fargo Overweight → Equal Weight
2019-12-03 Eingeleitet Cowen Outperform
2019-12-03 Eingeleitet Goldman Buy
2019-11-05 Eingeleitet Credit Suisse Outperform
2019-10-11 Eingeleitet Stifel Buy
2019-09-25 Eingeleitet Bernstein Outperform
2019-09-12 Eingeleitet Mizuho Buy
2019-07-30 Herabstufung Guggenheim Buy → Neutral
2019-07-08 Bestätigt Cantor Fitzgerald Overweight
2019-04-12 Eingeleitet Piper Jaffray Overweight
2019-03-29 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Uniqure N V Aktie (QURE) Neueste Nachrichten

pulisher
09:34 AM

(QURE) Investment Analysis - Stock Traders Daily

09:34 AM
pulisher
Nov 16, 2024

uniQure NV (LTS:0EE0) Enterprise Value : $-65.19 Mil (As of Nov. 16, 2024) - GuruFocus.com

Nov 16, 2024
pulisher
Nov 11, 2024

uniQure FY2024 EPS Estimate Reduced by Cantor Fitzgerald - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Privium Fund Management B.V. Acquires 104,500 Shares of uniQure (NASDAQ:QURE) - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Wall Street Analysts Believe uniQure (QURE) Could Rally 169.18%: Here's is How to Trade - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

(QURE) On The My Stocks Page - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 08, 2024

uniQure FY2024 EPS Estimate Boosted by Leerink Partnrs - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

HC Wainwright Issues Positive Estimate for uniQure Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

William Blair Issues Positive Estimate for uniQure Earnings - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - cnhinews.com

Nov 07, 2024
pulisher
Nov 07, 2024

What Does The Future Hold For uniQure N.V. (NASDAQ:QURE)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

QUREuniQure N.V. Latest Stock News & Market Updates - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Cantor Fitzgerald Reaffirms "Overweight" Rating for uniQure (NASDAQ:QURE) - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

uniQure Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

uniQure N.V. Reports Q3 2024 Progress and Financials - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewswire

Nov 05, 2024
pulisher
Nov 05, 2024

Uniqure NV earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia

Nov 05, 2024
pulisher
Nov 05, 2024

UniQure: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 05, 2024
pulisher
Nov 05, 2024

uniQure NV Q3 2024 Earnings: EPS Loss of $0.91 Beats Estimates, Revenue of $2.3 Million Misses Expectations - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

uniQure reports Q3 EPS (91c), consensus ($1.01) - TipRanks

Nov 05, 2024
pulisher
Nov 05, 2024

UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

uniQure's Breakthrough: Huntington's Trial Success, $435M Cash Runway Through 2027 | QURE Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 03, 2024

abrdn plc Buys 1,528,581 Shares of uniQure (NASDAQ:QURE) - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Assenagon Asset Management S.A. Has $1.34 Million Stake in uniQure (NASDAQ:QURE) - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Multiple Insiders Sold uniQure Shares Presenting Weak Signs For Investors - Simply Wall St

Nov 01, 2024
pulisher
Oct 29, 2024

UniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Oct 29, 2024
pulisher
Oct 26, 2024

uniQure (NASDAQ:QURE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Pfizer Loses Hemophilia Gene Therapy Patent Row To UniQure - Law360

Oct 25, 2024
pulisher
Oct 20, 2024

uniQure’s Yellow Flags: Early-Stage Gene Therapies Amid Restructuring - Seeking Alpha

Oct 20, 2024
pulisher
Oct 18, 2024

State Street Corp's Strategic Reduction in uniQure NV Holdings - GuruFocus.com

Oct 18, 2024
pulisher
Oct 18, 2024

How To Trade (QURE) - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

uniQure (NASDAQ:QURE) Upgraded to Sell by StockNews.com - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

uniQure (NASDAQ:QURE) Upgraded by StockNews.com to “Sell” - Defense World

Oct 17, 2024
pulisher
Oct 15, 2024

uniQure N.V. (QURE) requires closer examination - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

uniQure Initiates Trial for Promising ALS Gene Therapy - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

uniQure announces dosing of first patient in Phase I/II trial of AMT-162 - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment of SOD1-ALS - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS - StockTitan

Oct 15, 2024
pulisher
Oct 14, 2024

Raymond James gives an Outperform recommendation for uniQure N.V. (QURE) - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Ratios Uncovered: Breaking Down uniQure N.V. (QURE)’s Trailing Twelve Months Metrics - The Dwinnex

Oct 14, 2024
pulisher
Oct 13, 2024

Marshall Wace LLP Invests $175,000 in uniQure (NASDAQ:QURE) - Defense World

Oct 13, 2024
pulisher
Oct 10, 2024

uniQure shares coverage resumed on robust clinical portfolio - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Raymond James Reiterates Outperform Rating for uniQure (NASDAQ:QURE) - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

uniQure shares coverage resumed on robust clinical portfolio By Investing.com - Investing.com UK

Oct 10, 2024
pulisher
Oct 10, 2024

A company insider recently sold 1,447 shares of uniQure N.V. [QURE]. Should You Sale? - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

An analyst sees good growth prospects for uniQure N.V. (QURE) - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

Market Recap: uniQure N.V. (QURE)’s Positive Momentum, Closing at 5.92 - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

The uniQure N.V. (QURE) had a good session last reading, didn’t it? - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

uniQure N.V.’s Mixed Bag: Up 9.71% in 6 Months, Up 2.17% in 30 Days - The InvestChronicle

Oct 07, 2024
pulisher
Oct 02, 2024

uniQure (NASDAQ:QURE shareholders incur further losses as stock declines 10% this week, taking five-year losses to 89% - Simply Wall St

Oct 02, 2024
pulisher
Oct 01, 2024

Technical analysis of uniQure N.V. (QURE) stock chart patterns - US Post News

Oct 01, 2024

Finanzdaten der Uniqure N V-Aktie (QURE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):